Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modeling Adherence to Preventive Swallowing Exercises in Head and Neck Cancer

NCT03010150 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03010150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03010150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modeling Adherence to Preventive Swallowing Exercises in Head and Neck Cancer
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
December 29, 2016
Completion date
December 31, 2028
Enrollment
471 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma of unknown primary, clinical stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, clinical stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, metastatic head and neck carcinoma, metastatic malignant neoplasm in the uterine cervix, pathologic stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, pathologic stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, pathologic stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, stage i hypopharyngeal carcinoma ajcc v8, stage i nasopharyngeal carcinoma ajcc v8, stage ii hypopharyngeal carcinoma ajcc v8, stage ii laryngeal cancer ajcc v8, stage ii nasopharyngeal carcinoma ajcc v8, stage ii oropharyngeal (p16-negative) carcinoma ajcc v8, stage iii hypopharyngeal carcinoma ajcc v8, stage iii laryngeal cancer ajcc v8, stage iii nasopharyngeal carcinoma ajcc v8, stage iii oropharyngeal (p16-negative) carcinoma ajcc v8, stage iv hypopharyngeal carcinoma ajcc v8, stage iv laryngeal cancer ajcc v8, stage iv nasopharyngeal carcinoma ajcc v8, stage iv oropharyngeal (p16-negative) carcinoma ajcc v8, stage iva hypopharyngeal carcinoma ajcc v8, stage iva laryngeal cancer ajcc v8, stage iva nasopharyngeal carcinoma ajcc v8, stage iva oropharyngeal (p16-negative) carcinoma ajcc v8, stage ivb hypopharyngeal carcinoma ajcc v8, stage ivb laryngeal cancer ajcc v8, stage ivb nasopharyngeal carcinoma ajcc v8, stage ivb oropharyngeal (p16-negative) carcinoma ajcc v8